Importantly, in mice, systemic in vivo delivery of a transgene expressing this peptide can trigger p73-dependent tumor regression, thus confirming that it is possible to specifically activate tumor suppressor functions of TA-p73 in vivo by uncoupling the inhibitory action of iASPP [126]. Here, PPP1R13L is linked to neoplasm.